Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Malignant fibrous histiocytoma of the lung.
Aoe K, Hiraki A, Maeda T, Onoda T, Makihata K, Takao K, Fujii M, Murakami K, Moriyama M, Eda R, Takeyama H. Aoe K, et al. Among authors: murakami k. Anticancer Res. 2003 Jul-Aug;23(4):3469-74. Anticancer Res. 2003. PMID: 12926092 Review.
Pulmonary lymphoma of large B-cell type mimicking Wegener's granulomatosis.
Miyahara N, Eda R, Umemori Y, Murakami T, Kunichika N, Makihata K, Aoe K, Murakami K, Takeyama H, Harada M. Miyahara N, et al. Among authors: murakami t, murakami k. Intern Med. 2001 Aug;40(8):786-90. doi: 10.2169/internalmedicine.40.786. Intern Med. 2001. PMID: 11518126 Free article.
Blood DNA virome associates with autoimmune diseases and COVID-19.
Sasa N, Kojima S, Koide R, Hasegawa T, Namkoong H, Hirota T, Watanabe R, Nakamura Y, Oguro-Igashira E, Ogawa K, Yata T, Sonehara K, Yamamoto K, Kishikawa T, Sakaue S, Edahiro R, Shirai Y, Maeda Y, Nii T, Chubachi S, Tanaka H, Yabukami H, Suzuki A, Nakajima K, Arase N, Okamoto T, Nishikawa R, Namba S, Naito T, Miyagawa I, Tanaka H, Ueno M, Ishitsuka Y, Furuta J, Kunimoto K, Kajihara I, Fukushima S, Miyachi H, Matsue H, Kamata M, Momose M, Bito T, Nagai H, Ikeda T, Horikawa T, Adachi A, Matsubara T, Ikumi K, Nishida E, Nakagawa I, Yagita-Sakamaki M, Yoshimura M, Ohshima S, Kinoshita M, Ito S, Arai T, Hirose M, Tanino Y, Nikaido T, Ichiwata T, Ohkouchi S, Hirano T, Takada T, Tazawa R, Morimoto K, Takaki M, Konno S, Suzuki M, Tomii K, Nakagawa A, Handa T, Tanizawa K, Ishii H, Ishida M, Kato T, Takeda N, Yokomura K, Matsui T, Uchida A, Inoue H, Imaizumi K, Goto Y, Kida H, Fujisawa T, Suda T, Yamada T, Satake Y, Ibata H, Saigusa M, Shirai T, Hizawa N, Nakata K; Japan COVID-19 Task Force; Imafuku S, Tada Y, Asano Y, Sato S, Nishigori C, Jinnin M, Ihn H, Asahina A, Saeki H, Kawamura T, Shimada S, Katayama I, Poisner HM, Mack TM, Bick AG, Higasa K, Okuno T, Mochizuki H, Ishii M, Koike R, K… See abstract for full author list ➔ Sasa N, et al. Nat Genet. 2025 Jan 3. doi: 10.1038/s41588-024-02022-z. Online ahead of print. Nat Genet. 2025. PMID: 39753770
Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403).
Sugimoto N, Kawada J, Oka Y, Ueda S, Murakami K, Nishikawa K, Kurokawa Y, Fujitani K, Kawakami H, Endo S, Sakai D, Shimokawa T, Satoh T. Sugimoto N, et al. Among authors: murakami k. Anticancer Res. 2025 Jan;45(1):307-313. doi: 10.21873/anticanres.17418. Anticancer Res. 2025. PMID: 39740851 Clinical Trial.
4,646 results